Total Payments
$957,209
2024 Payments
$233,667
Companies
96
Transactions
1,781
Medicare Patients
3,325
Medicare Billing
$577,037
Payment Breakdown by Category
Other$653,293 (68.2%)
Consulting$156,267 (16.3%)
Travel$110,740 (11.6%)
Food & Beverage$36,292 (3.8%)
Education$616.83 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $635,456 | 262 | 66.4% |
| Consulting Fee | $156,267 | 77 | 16.3% |
| Travel and Lodging | $110,740 | 225 | 11.6% |
| Food and Beverage | $36,292 | 1,138 | 3.8% |
| Honoraria | $15,455 | 9 | 1.6% |
| Long term medical supply or device loan | $2,033 | 24 | 0.2% |
| Education | $616.83 | 45 | 0.1% |
| Grant | $350.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $278,073 | 270 | $0 (2024) |
| Daiichi Sankyo Inc. | $133,877 | 203 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $111,470 | 209 | $0 (2024) |
| Amgen Inc. | $65,161 | 101 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $45,923 | 50 | $0 (2023) |
| Genentech USA, Inc. | $43,891 | 99 | $0 (2023) |
| Medtronic, Inc. | $39,694 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $38,396 | 23 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $31,357 | 26 | $0 (2024) |
| GENZYME CORPORATION | $22,260 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233,667 | 188 | AstraZeneca Pharmaceuticals LP ($121,989) |
| 2023 | $120,921 | 207 | AstraZeneca Pharmaceuticals LP ($58,252) |
| 2022 | $163,537 | 265 | Daiichi Sankyo Inc. ($37,070) |
| 2021 | $102,655 | 203 | AstraZeneca Pharmaceuticals LP ($35,645) |
| 2020 | $46,534 | 167 | AstraZeneca Pharmaceuticals LP ($13,385) |
| 2019 | $170,033 | 304 | Amgen Inc. ($46,325) |
| 2018 | $95,154 | 247 | Novartis Pharmaceuticals Corporation ($58,574) |
| 2017 | $24,708 | 200 | Novartis Pharmaceuticals Corporation ($11,452) |
All Payment Transactions
1,781 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $685.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $460.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,360.00 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | PFIZER INC. | PADCEV (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,620.00 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,680.00 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,360.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $1,609.30 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $97.29 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Travel and Lodging | In-kind items and services | $694.26 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $66.25 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $2,010.00 | General |
| Category: Oncology | ||||||
| 11/24/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $535.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,360.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $26.46 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,340.00 | General |
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| 11/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,340.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 791 | 1,671 | $535,182 | $136,880 |
| 2022 | 9 | 823 | 1,580 | $382,378 | $137,205 |
| 2021 | 9 | 761 | 1,576 | $361,945 | $138,614 |
| 2020 | 11 | 950 | 1,929 | $456,107 | $164,337 |
Total Patients
3,325
Total Services
6,756
Medicare Billing
$577,037
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 135 | 711 | $269,387 | $73,620 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 307 | $84,088 | $20,970 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 299 | 397 | $66,753 | $16,698 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 89 | 89 | $50,372 | $10,835 | 21.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 38 | $21,736 | $4,661 | 21.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 46 | $17,848 | $4,323 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $13,011 | $2,706 | 20.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 37 | $7,659 | $2,140 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,328 | $927.25 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 163 | 727 | $209,483 | $78,332 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 287 | 374 | $30,231 | $17,211 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 156 | $28,341 | $9,999 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 75 | 75 | $31,986 | $9,989 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 69 | $39,468 | $9,984 | 25.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 113 | $23,391 | $6,105 | 26.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 23 | $8,924 | $2,256 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,300 | $1,832 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $4,254 | $1,498 | 35.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 136 | 673 | $195,236 | $74,500 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 296 | 414 | $32,715 | $19,778 | 60.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 231 | $42,183 | $17,331 | 41.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 82 | 82 | $34,768 | $11,165 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 42 | 46 | $26,312 | $6,964 | 26.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 61 | $12,627 | $3,369 | 26.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $8,750 | $2,430 | 27.8% |
About Dr. Kumar Abhishek, M.D
Dr. Kumar Abhishek, M.D is a Internal Medicine healthcare provider based in Mechanicsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083827018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kumar Abhishek, M.D has received a total of $957,209 in payments from pharmaceutical and medical device companies, with $233,667 received in 2024. These payments were reported across 1,781 transactions from 96 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($635,456).
As a Medicare-enrolled provider, Abhishek has provided services to 3,325 Medicare beneficiaries, totaling 6,756 services with total Medicare billing of $577,037. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Mechanicsville, VA
- Active Since 05/07/2007
- Last Updated 11/06/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083827018
Products in Payments
- IMFINZI (Biological) $81,928
- KISQALI (Drug) $70,760
- Enhertu (Drug) $70,667
- ENHERTU (Biological) $57,481
- Kyprolis (Biological) $52,773
- INJECTAFER (Drug) $33,698
- MEKINIST (Drug) $33,054
- ZEPZELCA (Drug) $31,333
- TAGRISSO (Drug) $29,403
- ENHERTU (Drug) $28,950
- ONIVYDE (Drug) $26,232
- BLENREP (Biological) $23,259
- OSTEOCOOL RF ABLATION SYSTEM (Device) $20,094
- TECENTRIQ (Biological) $19,878
- SARCLISA (Biological) $17,529
- INTELLIS ADAPTIVESTIM (Device) $17,259
- XPOVIO (Drug) $15,484
- Vitrakvi (Drug) $15,031
- NERLYNX (Drug) $14,078
- Lenvima (Drug) $13,580
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mechanicsville
Stanley Czajkowski, Md, MD
Internal Medicine — Payments: $16,593
Internal Medicine $16,593
Dr. Drew Jones, M.d, M.D
Internal Medicine — Payments: $14,249
Internal Medicine $14,249
Dr. Kenneth Roberts, Md, MD
Internal Medicine — Payments: $10,702
Internal Medicine $10,702
Timothy Wratchford, M.d, M.D
Internal Medicine — Payments: $10,601
Internal Medicine $10,601
Dr. Charles Payne, Md, MD
Internal Medicine — Payments: $9,869
Internal Medicine $9,869
Raquel Appa Falcao, Md, MD
Internal Medicine — Payments: $6,401
Internal Medicine $6,401